Risk assessment of esophageal variceal bleeding in B-viral liver cirrhosis by a liver stiffness measurement-based model

American Journal of Gastroenterology

Volumn 106, Issue 9, 2011, Pages 1654-1662

  Kim, Beom Kyung ^a   Kim, Do Young ^a,b,c   Han, Kwang Hyub ^a,b,c,d   Park, Jun Yong ^a,b,c   Kim, Ja Kyung ^a,b,c   Paik, Yong Han ^a,b,c,d   Lee, Kwan Sik ^a,b,c   Chon, Chae Yoon ^a,b,c   Ahn, Sang Hoon ^a,b,c  

^a Yonsei University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Liver Cirrhosis Clinical Research Center   (South Korea)

^d Yonsei University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; PROPRANOLOL;

ADULT; ARTICLE; ASTHENIA; BRADYCARDIA; CLINICAL ASSESSMENT TOOL; DIAGNOSTIC ACCURACY; DIZZINESS; DRUG DOSE REDUCTION; DYSPNEA; ESOPHAGEAL VARICES BLEEDING; ESOPHAGUS VARICES; FEMALE; HEMATOLOGICAL PARAMETERS; HUMAN; HYPOTENSION; LIVER CIRRHOSIS; LIVER STIFFNESS MEASUREMENT; MAJOR CLINICAL STUDY; MALE; PLATELET RATIO SCORE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SPLEEN DIAMETER; THROMBOCYTE COUNT;

ADULT; ELASTICITY IMAGING TECHNIQUES; ESOPHAGEAL AND GASTRIC VARICES; ESOPHAGOSCOPY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEPATITIS B; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; ORGAN SIZE; PLATELET COUNT; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; SPLEEN;

EID: 80052457597     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2011.160     Document Type: Article

References (36)

1. Bosch J, Berzigotti A, Garcia-Pagan JC et al. The management of portal hypertension: rational basis, available treatments and future options. J Hepatol 2008; 48 (Suppl 1): S68-92.
2. Merli M, Nicolini G, Angeloni ni S et al. Incidence and natural history of small esophageal varices in cirrhotic patients. J Hepatol 2003; 38: 266-72. (Pubitemid 36286538)
3. Mehta G, Abraldes JG, Bosch J. Developments and controversies in the management of oesophageal and gastric varices. Gut 2010; 59: 701-5.
4. Giannini E, Botta F, Borro P et al. Platelet count/spleen diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosis. Gut 2003; 52: 1200-5. (Pubitemid 36877436)
5. Kazemi F, Kettaneh A, N' Kontchou G et al. Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices. J Hepatol 2006; 45: 230-5.
6. Gentile I, Viola C, Graf M et al. A simple noninvasive score predicts gastroesophageal varices in patients with chronic viral hepatitis. J Clin Gastroenterol 2008; 43: 81-7.
7. Vizzutti F, Arena U, Romanelli RG et al. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology 2007; 45: 1290-7. (Pubitemid 46775793)
8. Berzigotti A, Gilabert R, Abraldes JG et al. Noninvasive prediction of clinically significant portal hypertension and esophageal varices in patients with compensated liver cirrhosis. Am J Gastroenterol 2008; 103: 1159-67. (Pubitemid 351677998)
9. Giannini EG, Zaman A, Kreil A et al. Platelet count/spleen diameter ratio for the noninvasive diagnosis of esophageal varices: results of a multicenter, prospective, validation study. Am J Gastroenterol 2006; 101: 2511-9. (Pubitemid 44665246)
10. Kovacevic N, Alempijevic T. Right liver lobe diameter: albumin ratio: a new non-invasive parameter for prediction of oesophageal varices in patients with liver cirrhosis (preliminary report). Gut 2007; 56: 1166-7; author reply 1167. (Pubitemid 47123251)
11. Rockey DC. Noninvasive assessment of liver fibrosis and portal hypertension with transient elastography. Gastroenterology 2008; 134: 8-14. (Pubitemid 350309358)
12. Castera L, Vergniol J, Foucher J et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005; 128: 343-50. (Pubitemid 40439195)
13. Lucidarme D, Foucher J, Le Bail B et al. Factors of accuracy of transient elastography (fibroscan) for the diagnosis of liver fibrosis in chronic hepatitis C. Hepatology 2009; 49: 1083-9.
14. Castera L, Le Bail B, Roudot-Th oraval F et al. Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores. J Hepatol 2009; 50: 59-68.
15. Kim BK, Han KH, Park JY et al. A liver stiffness measurement-based, noninvasive prediction model for high-risk esophageal varices in B-viral liver cirrhosis. Am J Gastroenterol 2010; 105: 1382-90.
16. Marcellin P, Ziol M, Bedossa P et al. Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B. Liver Int 2009; 29: 242-7.
17. Garcia-Tsao G, Sanyal AJ, Grace ND et al. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology 2007; 46: 922-38. (Pubitemid 47436138)
18. Dittrich M, Milde S, Dinkel E et al. Sonographic biometry of liver and spleen size in childhood. Pediatr Radiol 1983; 13: 206-11. (Pubitemid 13069001)
19. Ziol M, Handra-Luca A, Kettaneh A et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005; 41: 48-54. (Pubitemid 40066382)
20. Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology 2009; 50: 661-2.
21. Wiegand J, van Bommel F, Berg T. Management of chronic hepatitis B: status and challenges beyond treatment guidelines. Semin Liver Dis 2010; 30: 361-77.
22. European Association for the Study of the Liver. EASL clinical practice guidelines: management of chronic hepatitis B. J Hepatol 2009; 50: 227-42.
23. Liaw YF, Leung N, Kao JH et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update. Hepatol Int 2008; 2: 263-83.
24. Heagerty PJ, Lumley T, Pepe MS. Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics 2000; 56: 337-44. (Pubitemid 30422619)
25. Fluss R, Faraggi D, Reiser B. Estimation of the Youden index and its associated cutoffpoint. Biom J 2005; 47: 458-72. (Pubitemid 41229379)
26. Garcia-Tsao G, Bosch J. Management of varices and variceal hemorrhage in cirrhosis. N Engl J Med 2010; 362: 823-32.
27. Abraldes JG, Tarantino I, Turnes es J et al. Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis. Hepatology 2003; 37: 902-8. (Pubitemid 36397403)
28. Lo GH, Chen WC, Wang HM et al. Controlled trial of ligation plus nadolol versus nadolol alone for the prevention of first variceal bleeding. Hepatology 2010; 52: 230-7.
29. Gluud LL, Langholz E, Krag A. Meta-analysis: isosorbide-mononitrate alone or with either beta-blockers or endoscopic therapy for the management of oesophageal varices. Aliment Pharmacol Ther 2010; 32: 859-71.
30. Giannini EG. Review article: thrombocytopenia in chronic liver disease and pharmacologic treatment options. Aliment Pharmacol Ther 2006; 23: 1055-65. (Pubitemid 43779344)
31. Poynard T, Trabut JB, Ratziu V et al. Prediction of oesophageal varices with platelet count/spleen diameter ratio or platelets alone. Gut 2004; 53: 913-4; author reply 914.
32. O' Donohue J, Ng C, Catnach S et al. Diagnostic value of Doppler assessment of the hepatic and portal vessels and ultrasound of the spleen in liver disease. Eur J Gastroenterol Hepatol 2004; 16: 147-55. (Pubitemid 39049650)
33. Sandrin L, Fourquet B, Hasquenoph JM et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003; 29: 1705-13. (Pubitemid 38091720)
34. Liu CH, Lin JW, Tsai FC et al. Noninvasive tests for the prediction of significant hepatic fibrosis in hepatitis C virus carriers with persistently normal alanine aminotransferases. Liver Int 2006; 26: 1087-94.
35. Deugnier Y, Turlin B. Pathology of hepatic iron overload. World J Gastroenterol 2007; 13: 4755-60. (Pubitemid 47455566)
36. Gandon Y, Olivie D, Guyader D et al. Non-invasive assessment of hepatic iron stores by MRI. Lancet 2004; 363: 357-62. (Pubitemid 38169542)